Instrument Inactif

Autres langues Nektar Therapeutics Nasdaq

Actions

Recherche biotechnologique et médicale

Autres langues

31/08	Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
28/08	Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25/08	Nektar Therapeutics Publishes Positive Phase 2B Rezolve-Ad 16-Week Induction Results of Rezpegaldesleukin in Moderate-To-Severe Atopic Dermatitis
25/08	Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis
13/08	Nektar: Q2 Earnings Snapshot
13/08	Nektar Therapeutics Q2 Loss Narrows, Revenue Declines
13/08	Earnings Flash (NKTR) Nektar Therapeutics Posts Q2 Loss $1.23 Per Share, vs. FactSet Est of $1.97 Loss
13/08	Nektar Therapeutics Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
13/08	Earnings Flash (NKTR) Nektar Therapeutics Reports Q2 Revenue $10.1M, vs. FactSet Est of $10.4M
13/08	Nektar Therapeutics Announces Second Quarter 2026 Financial Results
29/07	Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets
24/07	Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21/07	Nektar Therapeutics Announces Start Of Phase 3 Zenith AD Program Evaluating Rezpegaldesleukin In Moderate-To-Severe Atopic Dermatitis
21/07	Nektar Initiates Two Registrational Trials in Phase 3 Program Evaluating Atopic Dermatitis Treatment
21/07	Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis
29/06	Nektar Therapeutics(NasdaqCM:NKTR) added to Russell Small Cap Comp Growth Benchmark
29/06	Nektar Therapeutics(NasdaqCM:NKTR) added to Russell 2000 Index
29/06	Nektar Therapeutics(NasdaqCM:NKTR) added to Russell 2500 Growth Benchmark
29/06	Nektar Therapeutics(NasdaqCM:NKTR) added to Russell 2000 Value Benchmark
29/06	Nektar Therapeutics(NasdaqCM:NKTR) added to Russell 2000 Growth Benchmark
29/06	Nektar Therapeutics(NasdaqCM:NKTR) added to Russell 3000E Index
29/06	Nektar Therapeutics(NasdaqCM:NKTR) added to Russell 3000E Growth Benchmark
29/06	Nektar Therapeutics(NasdaqCM:NKTR) added to Russell 3000E Value Benchmark
29/06	Nektar Therapeutics(NasdaqCM:NKTR) added to Russell 2000 Dynamic Index
29/06	Nektar Therapeutics(NasdaqCM:NKTR) added to Russell 3000 Value Benchmark